FMP

FMP

Enter

ARMP - Armata Pharmaceutica...

photo-url-https://images.financialmodelingprep.com/symbol/ARMP.png

Armata Pharmaceuticals, Inc.

ARMP

AMEX

Armata Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus aureus bacteremia; AP-PA02 for Pseudomonas aeruginosa; and AP-PA03 for the treatment of pneumonia. It has a partnership agreement with Merck & Co. for developing synthetic bacteriophage candidates to target undisclosed infectious disease agents. The company is headquartered in Marina del Rey, California.

2.24 USD

0.18 (8.04%)

About

ceo

Dr. Deborah L. Birx M.D.

sector

Healthcare

industry

Biotechnology

exchange

AMEX

Description

Armata Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus aureus bacteremia; AP-PA02 for Pseudomonas aeruginosa; and AP-PA03 for the treatment of pneumonia. It has a partnership agreement with Merck & Co. for developing synthetic bacteriophage candidates to target undisclosed infectious disease agents. The company is headquartered in Marina del Rey, California.

CIK

0000921114

ISIN

US04216R1023

CUSIP

04216R102

Address

4503 Glencoe Avenue

Phone

858 829 0829

Country

US

Employee

66

IPO Date

May 20, 1994

Key Executives

Name

Title

Pay

Year Born

Dr. Mina Pastagia M.D., MS

Chief Medical Officer

463.75k

1975

Mr. Peter Hubbard

Vice President of Operations

0

N/A

Mr. David House

Senior Vice President of Finance & Princ...

0

N/A

Dr. Pierre Kyme Ph.D.

Chief Business Officer

0

N/A

Dr. Deborah L. Birx M.D.

Chief Executive Officer & Director

536.43k

1957

As of December 31, 2024, the total employee count stands at 66, with compensation values reflecting the last fiscal year ending on that date. Pay encompasses salary, bonuses, etc., All figures are in USD.

FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep